Shortage of human intravenous immunoglobulin—reasons and possible solutions
暂无分享,去创建一个
[1] L. Cavacini,et al. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. , 2006, The New England journal of medicine.
[2] J. Ravetch,et al. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.
[3] O. Abdel-Wahab,et al. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature , 2006, Transfusion.
[4] A. Buchacher,et al. Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety , 2006, Biotechnology journal.
[5] J. Callum,et al. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995–2000 , 2005, Vox sanguinis.
[6] J. Freedman,et al. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? , 2005, The Journal of clinical investigation.
[7] C. Schreiner,et al. Properties of a new intravenous immunoglobulin (IGIV‐C, 10%) produced by virus inactivation with caprylate and column chromatography , 2003, Vox sanguinis.
[8] S. Kaveri,et al. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. , 2001, The New England journal of medicine.
[9] S. Kaveri,et al. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice , 1999, European journal of immunology.
[10] W. Fridman,et al. Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura , 1993, The Lancet.
[11] W. Fridman,et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. , 1993, Lancet.